Company Insight

Mimotopes’ Custom Antibodies are Your Secret Research Weapon

Tailored solutions for your Immunoassay needs.

Main image credit: 

in biomedical research, having the right tools can make all the difference. Mimotopes, known for their pioneering work in custom peptide synthesis, now brings their expertise to the forefront of antibody production. Whether you're in need of specific antibodies for immunoassays or robust screening services, Mimotopes has the solutions you require.

Polyclonal Antibodies: Efficiency Without Compromise

Mimotopes specializes in generating high-quality polyclonal antibodies, streamlining the development process that typically accompanies monoclonal antibodies. This approach not only saves time but also ensures reliable and effective reagents for your research.

One of the highlights of Mimotopes' offerings is their proficiency in designing and producing affinity-purified rabbit anti-peptide antibodies. These antibodies are essential in applications like the Sandwich ELISA, where specificity and sensitivity are paramount. With typical detection sensitivity in the low ng/mL range, Mimotopes' antibodies provide the precision needed for accurate and dependable results.

Standard Rabbit Package Deliverables

(2 New Zealand rabbits) 

Serum 

Antibody 

Protein Package 

  • (supplied by customer)

IMM001 

  • Preimmune Serum (1 mL) 
  • Hyperimmune Serum (40-60mL) 
  • Titre report 10-12 weeks 


IMM002 

  • Preimmune Serum (1 mL) 
  • 2-5mg
  • Titre report 12-15 weeks 

Peptide Package 

  • 12-22mer, >85% purity 
  • Peptide conjugated to carrier 
  • (KLH, Ova, BSA)

IMM003 

  • 3mg peptide
  • Preimmune Serum (1mL) 
  • Hyperimmune Serum (40-60mL) 
  • Titre report 12-15 weeks 

IMM004 

  • 3mg peptide 
  • Preimmune Serum (1mL) 
  • 5mg affinity purified 
  • antibody 
  • Titre report 12-15 weeks 

Affinity enhanced Peptide Package 

  • Phospho peptide (enquire for methylated, formylated etc) 
  • Peptide conjugated to carrier protein


IMM005 

  • Preimmune Serum (1 mL) 
  • 3mg peptide(NP) 
  • 3mg phosphorylated peptide (P) 
  • 5mg affinity purified antibody (NP) 
  • 5mg affinity purified antibody (P) 
  • Titre report 13-16 weeks 


  • All Polyclonal packages come with a QA report which includes HPLC and MS trace for peptides, a conjugate report and an ELISA data sheet
  • All anti-peptide packages come with an ELISA guarantee >1:50,000
  • Protein packages have DOT BLOT confirmation
  • Standard packages have a 63-day immunization protocol; this may be extended to achieve guaranteed titres
  • Express or customized protocols can be utilized upon request

Comprehensive Antibody Services

From serum purification to peptide conjugation, Mimotopes offers a complete suite of products and services tailored to your immunization and antibody needs: 

Affinity Support Products: Purify your serum to obtain specific antibodies with ease.
​​​​​​​High-Quality Peptides: Mimotopes provides purified peptides conjugated to immunogenic protein carriers, such as Keyhole Limpet Hemocyanin (KLH), Bovine Serum Albumin (BSA), or Ovalbumin.

Mimotopes' flexibility allows for both standard and customized polyclonal packages, ensuring that your unique requirements are met. They offer a range of options from basic serum antibody packages to more complex peptide packages that include affinity-purified antibodies.

Advanced Screening and Assay Development

Mimotopes doesn't stop at antibody production. They also provide expert assay development and screening services, including:

Epitope Mapping: Identify specific regions on proteins that antibodies can target. 
Competition ELISA: Evaluate the binding affinity of your antibodies. 
Assay Development: Tailor assays specific to your research needs.

Additionally, Mimotopes' PepSet™ libraries are invaluable for T-cell mapping, helping researchers gain deeper insights into immune responses.

Why Choose Mimotopes?

With a legacy of innovation and quality, Mimotopes continues to push the boundaries of what's possible in peptide and antibody technology. Their comprehensive range of products and services, backed by rigorous quality assurance protocols, ensures that researchers have the tools they need to advance their work confidently.

Mimotopes is ready to assist with designing and coordinating antibody production specific to your protein of interest. With offices and support available worldwide, they are equipped to meet the demands of the global research community.

Stay tuned for our newest offering: Camelid nanobodies, which are derived from llamas, alpacas, and camels, and provide unique immune responses.

For more information or to get started with your custom antibody project, contact Mimotopes today. 

Contact information

Mimotopes 
Suite 1, Unit 9 / 677 Springvale Rd, 
Mulgrave, VIC 3170 Australia 

Tel.: +61 3 9565 1111 
Email: mimotopes@mimotopes.com 
Web: www.mimotopes.com

Go to article: Home | US reproductive laws could limit women’s participation in clinical trialsGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: Avenga Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: InterphexGo to article: Investment and Development Agency of Latvia Company InsightGo to article: In DepthGo to article: US reproductive laws could limit women’s participation in clinical trialsGo to article: How Pfizer management outplayed activist investor StarboardGo to article: Trump 2.0 spells global change in pharmaceutical regulation, funding and investmentGo to article: Flu vaccine strategy on the line as new US leaders anticipated to take chargeGo to article: Lilly’s £279m bet aims to boost UK life sciences sectorGo to article: PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amassGo to article: DatwylerGo to article: Pharma Event GuideGo to article: In this guideGo to article: Avenga Company InsightGo to article: AST Company InsightGo to article: ICROM Company InsightGo to article: Girteka Company InsightGo to article: 2024 Event HighlightsGo to article: Swiss biotech ecosystem recuperates from global financial instabilityGo to article: Cell and gene therapy approvals drive paradigm change in manufacturingGo to article: Will the tide turn for the wave of pharma layoffs?Go to article: AIDS 24: Prioritise at risk populations for trials, testing and treatmentGo to article: Pharma readies for climate disasters amidst supply chain concernsGo to article: Amgen showcases exciting potential in the obesity space at JPM24 Go to article: Experts call for a shift from reactive to proactive clinical trial supply frameworksGo to article: 2025 Event CalendarGo to article: InterphexGo to article: Advertise with usGo to article: ListingsGo to article: Pharmaceutical Technology Excellence Awards 2024 winnersGo to article: Buyer's GuidesGo to article: Next issue